BTG2 and gastric cancer: Notable targets up-regulated by PKNOX2 include BTG2, a tumor suppressor with anti-proliferative and anti-metastatic properties [26, 27], and RPRM, which has been reported to suppress tumorigenesis in gastric cancer [28].